source
- Veradermics reports positive Phase 3 results for oral baldness pillVeradermics said its experimental oral formulation of minoxidil met the primary goal of its Phase 3 trial, showing significantly more new hair growth over six months compared with placebo. The dru…
- Intellia reports positive Phase 3 readout for CRISPR gene-editing therapy in hereditary angioedemaIntellia Therapeutics announced that its CRISPR-based therapy achieved a successful readout in a Phase 3 trial for hereditary angioedema, a rare condition marked by sudden, potentially dangerous sw…